ArticleClinical epigenetics2019

Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.

Shivani Kamdar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.